Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03551977
Other study ID # 1310 63221
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 28, 2017
Est. completion date June 15, 2018

Study information

Verified date November 2022
Source University of Agder
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Research evidence shows that prevalence of pain in adolescents is increasing and is therefore recognized as a growing health problem. Psychological interventions delivered remotely through the internet may reduce intensity or severity of pain among children and adolescents with chronic pain. The iCanCope with Pain program is an existing web- and mobile-based self-management program, which is developed as a multi-center study funded by the Canadian Institutes of Health Research and is based on identified health care needs and current best practices for pain self-management. Objectives: The primary objectives are to describe the translation and cultural adaptation of the Norwegian version of the iCanCope with Pain mobile application and evaluate the effect in an upcoming randomized controlled trail with adolescents with chronic pain. Study sample: 16-19-year-old adolescents with self-declared persistent and/or chronic pain. Recruited from high schools in Southern Norway. Theoretical framework: Cognitive behavioral therapy (CBT) is explained by an integration of behavioral and cognitive theories of human behavior and psychopathology and is often the preferred treatment of choice for adolescents with different health disorders. The theoretical framework of CBT is integrated in the iCanCope with Pain app in terms of five components. The intervention group will receive the app with all five components: (I) symptom trackers for pain, sleep, mood, physical, and social function; (II) goal setting to improve pain and function; (III) coping toolbox of pain self-management strategies; (IV) social support; (V) age-appropriate pain education. The control group will receive the app with only the first self-registration component (I) symptom trackers for pain, sleep, mood, physical, and social function. Methods: Both qualitative and quantitative data will be gathered for evaluating the Norwegian version of the iCanCope with Pain app. Usability testing are assessed in both laboratory settings and in field using observation, interviews and questionnaires, which provide necessary information for an upcoming randomized controlled trail (RCT). Outcomes will in the RCT be measured at baseline (mid-April) and after an 8 weeks intervention (mid-June). The study is part of a PhD project.


Recruitment information / eligibility

Status Completed
Enrollment 112
Est. completion date June 15, 2018
Est. primary completion date June 15, 2018
Accepts healthy volunteers No
Gender All
Age group 16 Years to 19 Years
Eligibility Inclusion Criteria: 1. 16-19-year-old adolescents 2. with persistent and/or chronic pain, weekly suffered and lasting 3 months or more based on subjective reporting 3. be able to read and understand Norwegian 4. have their own smartphone. Exclusion Criteria: 1. Adolescents with cognitive disability or diseases, because of the risk of not correctly understanding the iCanCope with Pain program via self-report, goal setting and/or library reading. 2. Adolescents that have participated in the usability testing of the Norwegian iCanCope with Pain app 3. Adolescents with diagnoses from a pathological or medical origin (e.g hematology/oncology patients) will also be excluded because the program was not specifically designed for these pain groups.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
iCanCope with Pain
The participants are free to use the Norwegian iCanCope with Pain app as much as they want during the 8 week intervention period. The only support available is technical support.
iCanCope with Pain control
The participants are free to use the Norwegian iCanCope with Pain control app as much as they want during the 8 week intervention period. The only support available is technical support.

Locations

Country Name City State
Norway Erik Grasaas Kristiansand

Sponsors (2)

Lead Sponsor Collaborator
University of Agder The Hospital for Sick Children

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Attrition rate Change in participants completed the post-questionnaire divided by the number of participants at baseline. Baseline and 8-weeks
Primary App engagement Completion of daily symptom check-ins was used as a proxy for app engagement. Baseline to 8 weeks.
Secondary Physical activity Change in total score of the International Physical Activity Questionnaire (IPAQ). Higher values at post-intervention represent a better outcome. Baseline and 8 weeks (post-intervention)
Secondary Coping Change in total score of the General Self-Efficacy Questionnaire Short Version (GSEQ). Higher values at post-intervention represent a better outcome. Baseline and 8 weeks (post-intervention)
Secondary Social participation Change in total score of school absence (General Information Questionnaire). Lower values at post-intervention represent a better outcome. Baseline and 8 weeks (post-intervention)
Secondary Over-The-Counter (OTC) analgesics Change in total score of OTC analgesics consumption (General Information Questionnaire). Lower values at post-intervention represent a better outcome. Baseline and 8 weeks (post-intervention)
Secondary Perceived social support from friends Change in total score of the Perceived Social Support from friends Questionnaire (PSS). Higher values at post-intervention represent a better outcome. Baseline and 8 weeks (post-intervention)
Secondary Pain self-efficacy questionnaire Change in total score of the Pain Self-Efficacy Questionnaire (PSEQ). Higher values at post-intervention represent a better outcome. Baseline and 8 weeks (post-intervention)
Secondary Anxiety and depression Change in total score of the Hospital Anxiety and Depression Scale Questionnaire (HADS). Lower values at post-intervention represent a better outcome. Baseline and 8 weeks (post-intervention)
Secondary Global impression of change Change in Patients' Global Impression of Change Scale (PGIC) from 1-7. Higher values at post-intervention represent a better outcome. After 8 weeks (post-intervention)
Secondary Health-related quality of life (HRQOL) Change in total score of the Kidscreen 52 Questionnaire. Higher values at post-intervention represent a better outcome. Baseline and 8 weeks (post-intervention)
Secondary Pain experience Change in total score of the Lubeck Pain Questionnaire (LPQ). Lower values at post-intervention represent a better outcome. Baseline and 8 weeks (post-intervention)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care